Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

EverSlim Tirzepatide Review: Cost, Named Pharmacies & Honest Verdict (2026)

An honest 2026 review of EverSlim tirzepatide — three named pharmacies, LegitScript and NABP accreditation, and a pricing page that 404s.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Care Bare Rx

LegitScript-certified, with oral as well as injectable tirzepatide and a real brand Ozempic pathway — but per-dose pricing is quiz-gated.

From $199/mo*

Check Care Bare Rx availability

EverSlim: $140/month for tirzepatide and $117/month for semaglutide, with three named pharmacy partners — EPIQ Scripts, Foothills, and Emerald — plus genuine LegitScript and NABP accreditation. Every fact here comes from the company's own published program.

What EverSlim is

EverSlim is a US telehealth program, selling doctor-prescribed compounded GLP-1 medication delivered to your door across all 50 states and DC. It names its pharmacy partners — EPIQ Scripts, Foothills, and Emerald — plus its medical group, DrTelx, and carries genuine LegitScript and NABP accreditation.

§ EverSlim — Named Partners and the Missing Pricing Page

ItemStatus
Tirzepatide$140/mo
Named pharmaciesEPIQ Scripts, Foothills, Emerald —
Dose-tier pricingUnpublished — /pricing page 404s
Verified: $140/mo tirzepatide, $117/mo semaglutide, LegitScript and NABP accredited. /pricing returns a 404.

What EverSlim costs

$140/month for tirzepatide and $117/month for semaglutide — transparent flat figures with medication, provider visit, and shipping included, no insurance required. Worth flagging directly: EverSlim's dedicated /pricing page returns a 404, the footer pricing link is only a same-page anchor, and full checkout sits behind a login — so what a titrated dose actually costs beyond the starting figures is unknowable before you sign up.

A 'no membership' claim that contradicts its own cancellation terms

EverSlim's marketing says "No membership", but the cancellation policy itself repeatedly refers to the arrangement as a membership and subscription — a direct contradiction worth reading closely. Cancellation requires at least 72 hours' notice before the next billing date, or the subscription renews automatically.

Asynchronous care in most states, live visits required in a few

EverSlim offers asynchronous care in 44 states, but DC, Kansas, Louisiana, Mississippi, New Mexico, Rhode Island, and West Virginia require a live video consult instead — confirm which applies to your state.

The brand-vs-compounded question

EverSlim dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

EverSlim's real strengths: three named pharmacy partners, a named medical group, and genuine LegitScript and NABP accreditation — a rare combination of disclosure signals. The trade-offs are real: no dose-tier pricing is published anywhere, the pricing page itself 404s, cancellation requires 72 hours' notice, its "no membership" marketing contradicts its own cancellation terms, and 7 states require a live video consult rather than the asynchronous flow. As with any GLP-1 program, ask directly what a titrated dose will cost before signing up, since that's genuinely unknowable from the public site; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

EverSlim's named pharmacies and genuine LegitScript/NABP accreditation are real transparency strengths, but the missing dose-tier pricing and the "no membership" claim contradicting its own cancellation terms are worth reading closely before signing up. If fully published pricing at every tier matters more to you, compare it against bmiMD or CoreAge Rx. Another provider on a similar non-calendar billing cycle with thin disclosure is Independent Wellness. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through EverSlim?

$140/month, as a starting figure. Dose-tier pricing beyond that isn't published — the site's dedicated /pricing page returns a 404.

Does EverSlim name its compounding pharmacy?

Yes — three partners: EPIQ Scripts, Foothills, and Emerald.

Can I cancel EverSlim easily?

Cancellation requires at least 72 hours' notice before the next billing date, and the marketing's "no membership" claim contradicts the cancellation policy's own use of "membership" and "subscription" language.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.